Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related VECO
Earnings Scheduled For February 16, 2017
Wall Street's M&A Chatter From February 2
Related UTHR
Your Guide To 2017's Emerging Pharmaceuticals Catalysts
13 Emerging Biotechs With Catalysts In 2017
Notable earnings before Wednesday's open (Seeking Alpha)

Analysts at B. Riley downgraded Veeco Instruments (NASDAQ: VECO) from “buy” to “neutral.” Veeco's shares closed at $30.55 yesterday. Veeco's trailing-twelve-month ROA is 5.44%.

Analysts at Goldman Sachs downgraded United Therapeutics (NASDAQ: UTHR) from “neutral” to “sell.” United Therapeutics' shares closed at $52.16 yesterday. United Therapeutics' trailing-twelve-month ROE is 24.64%.

Analysts at Jefferies downgraded Nabors Industries (NYSE: NBR) from “hold” to “underperform.” Nabors Industries' shares closed at $14.53 yesterday. Nabors Industries' trailing-twelve-month profit margin is 0.44%.

Keefe Bruyette downgraded Comerica (NYSE: CMA) from “market perform” to “underperform.” Comerica's shares closed at $29.27 yesterday. Comerica's PEG ratio is 0.95.

Latest Ratings for VECO

DateFirmActionFromTo
Feb 2017Bank of AmericaUpgradesNeutralBuy
Oct 2016UBSMaintainsBuy
Oct 2016KeyBancMaintainsOverweight

View More Analyst Ratings for VECO
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CMA + NBR)

View Comments and Join the Discussion!